Cargando…

Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China

BACKGROUND: Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongxin, Zhou, Lin, Zhao, Yong, Ma, Lijuan, Liu, Xiaoyan, Hu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359455/
https://www.ncbi.nlm.nih.gov/pubmed/32660436
http://dx.doi.org/10.1186/s12879-020-05241-x
_version_ 1783559053348175872
author Li, Hongxin
Zhou, Lin
Zhao, Yong
Ma, Lijuan
Liu, Xiaoyan
Hu, Jin
author_facet Li, Hongxin
Zhou, Lin
Zhao, Yong
Ma, Lijuan
Liu, Xiaoyan
Hu, Jin
author_sort Li, Hongxin
collection PubMed
description BACKGROUND: Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the molecular epidemiological characteristics and antimicrobial resistance of GAS isolates from patients in Children’s Hospital in Beijing. METHODS: From 2016 to 2017, pharyngeal swab samples were collected from the outpatients in Children’s Hospital, Capital Institute of Pediatrics, who were diagnosed with scarlet fever. Antimicrobial susceptibility test was performed according to the distribution of conventional antibiotics and Clinical and Laboratory Standards Institute (CLSI) recommendations. The distribution of the macrolide-resistance genes (ermB, ermA, mefA), emm (M protein-coding gene) typing, and superantigens (SAg) gene profiling were examined by polymerase chain reaction (PCR). RESULTS: A total of 297 GAS isolates were collected. The susceptibility of the isolates to penicillin, ceftriaxone, and levofloxacin was 100%. The resistance rate to erythromycin and clindamycin was 98.3 and 96.6%, respectively. The dominant emm types were emm12 (65.32%), emm1 (27.61%), emm75 (2.69%), and emm89 (1.35%). Of the 297 isolates, 290 (97.64%) carried the ermB gene, and 5 (1.68%) carried the mefA gene, while none carried the ermA gene. The most common superantigen genes identified from GAS isolates were smeZ (96.97%), speC (92.59%), speG (91.58%), ssa (85.52%), speI (54.55%), speH (52.19%), and speA (34.34%). Isolates with the genotype emm1 possessed speA, speC, speG, speJ, speM, ssa, and smeZ, while emm12 possessed speC, speG, speH, speI, speM, ssa, and smeZ superantigens. CONCLUSIONS: The prevalent strain of GAS isolates in Beijing has a high resistance rate to macrolides; however, penicillin can still be the preferred antibiotic for treatment. Erythromycin resistance was predominantly mediated by ermB. The common emm types were emm12 and emm1. There was a correlation between emm and the superantigen gene. Thus, long-term monitoring and investigation of the emm types and superantigen genes of GAS prevalence are imperative.
format Online
Article
Text
id pubmed-7359455
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73594552020-07-17 Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China Li, Hongxin Zhou, Lin Zhao, Yong Ma, Lijuan Liu, Xiaoyan Hu, Jin BMC Infect Dis Research Article BACKGROUND: Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the molecular epidemiological characteristics and antimicrobial resistance of GAS isolates from patients in Children’s Hospital in Beijing. METHODS: From 2016 to 2017, pharyngeal swab samples were collected from the outpatients in Children’s Hospital, Capital Institute of Pediatrics, who were diagnosed with scarlet fever. Antimicrobial susceptibility test was performed according to the distribution of conventional antibiotics and Clinical and Laboratory Standards Institute (CLSI) recommendations. The distribution of the macrolide-resistance genes (ermB, ermA, mefA), emm (M protein-coding gene) typing, and superantigens (SAg) gene profiling were examined by polymerase chain reaction (PCR). RESULTS: A total of 297 GAS isolates were collected. The susceptibility of the isolates to penicillin, ceftriaxone, and levofloxacin was 100%. The resistance rate to erythromycin and clindamycin was 98.3 and 96.6%, respectively. The dominant emm types were emm12 (65.32%), emm1 (27.61%), emm75 (2.69%), and emm89 (1.35%). Of the 297 isolates, 290 (97.64%) carried the ermB gene, and 5 (1.68%) carried the mefA gene, while none carried the ermA gene. The most common superantigen genes identified from GAS isolates were smeZ (96.97%), speC (92.59%), speG (91.58%), ssa (85.52%), speI (54.55%), speH (52.19%), and speA (34.34%). Isolates with the genotype emm1 possessed speA, speC, speG, speJ, speM, ssa, and smeZ, while emm12 possessed speC, speG, speH, speI, speM, ssa, and smeZ superantigens. CONCLUSIONS: The prevalent strain of GAS isolates in Beijing has a high resistance rate to macrolides; however, penicillin can still be the preferred antibiotic for treatment. Erythromycin resistance was predominantly mediated by ermB. The common emm types were emm12 and emm1. There was a correlation between emm and the superantigen gene. Thus, long-term monitoring and investigation of the emm types and superantigen genes of GAS prevalence are imperative. BioMed Central 2020-07-13 /pmc/articles/PMC7359455/ /pubmed/32660436 http://dx.doi.org/10.1186/s12879-020-05241-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Hongxin
Zhou, Lin
Zhao, Yong
Ma, Lijuan
Liu, Xiaoyan
Hu, Jin
Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_full Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_fullStr Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_full_unstemmed Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_short Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_sort molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in beijing, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359455/
https://www.ncbi.nlm.nih.gov/pubmed/32660436
http://dx.doi.org/10.1186/s12879-020-05241-x
work_keys_str_mv AT lihongxin molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT zhoulin molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT zhaoyong molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT malijuan molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT liuxiaoyan molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT hujin molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina